Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Quest Diagnostics Inc (DGX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 11,726,686
  • Shares Outstanding, K 136,072
  • Annual Sales, $ 7,709 M
  • Annual Income, $ 772,000 K
  • 36-Month Beta 0.90
  • Price/Sales 1.53
  • Price/Cash Flow 11.52
  • Price/Book 2.16

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 1.36
  • Number of Estimates 9
  • High Estimate 1.40
  • Low Estimate 1.29
  • Prior Year 1.38
  • Growth Rate Est. (year over year) -1.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
78.95 +9.16%
on 12/26/18
87.33 -1.32%
on 01/18/19
+4.48 (+5.48%)
since 12/21/18
3-Month
78.95 +9.16%
on 12/26/18
98.25 -12.28%
on 11/09/18
-15.36 (-15.13%)
since 10/22/18
52-Week
78.95 +9.16%
on 12/26/18
116.49 -26.02%
on 06/25/18
-17.39 (-16.79%)
since 01/22/18

Most Recent Stories

More News
Quest Diagnostics Named One of 2019 "World's Most Admired Companies" by Fortune Magazine for Fourth Consecutive Year

Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that it has been selected as one of FORTUNE's World's Most Admired Companies in 2019 for...

DGX : 86.18 (-0.99%)
Quest Diagnostics' Core Diagnostics Strong Amid Several Woes

Quest Diagnostics' (DGX) steady efforts to intensify focus on core diagnostic information services business and an intelligent capital management give investors ample reasons to cheer for.

DGX : 86.18 (-0.99%)
AMED : 124.74 (-1.87%)
ILMN : 303.62 (-2.92%)
VEEV : 103.11 (-2.75%)
William Moore Appointed as Cerus Corporation's Senior Vice President of Manufacturing Operations and Supply Chain

Cerus Corporation (Nasdaq:CERS) announced today the appointment of William Moore to the newly created position of Senior Vice President of Manufacturing Operations and Supply Chain for Cerus,...

DGX : 86.18 (-0.99%)
CERS : 5.63 (-0.88%)
Quest Diagnostics To Speak At The 37th Annual J.P. Morgan Healthcare Conference

Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the 37th Annual J. P. Morgan Healthcare Conference...

DGX : 86.18 (-0.99%)
JPM : 102.94 (-1.58%)
Quest Diagnostics (DGX) Divests India Business to Strand

Quest Diagnostics (DGX) sees lucrative prospects in the U.S. diagnostic testing market.

ITGR : 78.13 (-3.15%)
DGX : 86.18 (-0.99%)
VEEV : 103.11 (-2.75%)
OPK : 3.68 (-3.16%)
Workforce Drug Positivity Rises by Double-Digits in Almost One-Third of U.S. Industry Sectors Examined, According to New Quest Diagnostics Analysis

Drug use by the U.S. workforce increased each year -- and by double-digits over two years -- between 2015 and 2017, in five of 16 major U.S. industry sectors analyzed, according to a first-ever analysis...

DGX : 86.18 (-0.99%)
Amazon Eyeing Diagnostic Space to Gather Steam in Healthcare

Amazon's (AMZN) growing healthcare initiatives are likely to aid its growth in the healthcare supply chain management market.

GOOGL : 1,078.63 (-2.59%)
DGX : 86.18 (-0.99%)
LH : 135.70 (-1.45%)
AMZN : 1,632.17 (-3.77%)
Look for Shares of Quest Diagnostic to Potentially Rebound after Yesterday's 1.03% Sell Off

Quest Diagnostic (NYSE:DGX) traded in a range yesterday that spanned from a low of $87.33 to a high of $88.20. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $87.39...

DGX : 86.18 (-0.99%)
The Cancer Screening Market in China (2018-2023) by End-User, Screening Type and Application - Quest Diagnostics, Hologic, Qiagen, F. Hoffmann-La Roche, and Abbott Laboratories are Dominating - ResearchAndMarkets.com

The "Cancer Screening Market in China (2018-2023)" report has been added to ResearchAndMarkets.com's offering.

HOLX : 44.19 (+0.16%)
ABT : 71.49 (+0.10%)
DGX : 86.18 (-0.99%)
Shares of Laboratory Cp Rank the Highest in Terms of Relative Performance in the Health Care Services Industry (LH , PINC , DGX , ESRX , AMED )

Here are the top 5 stocks in the Health Care Services industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

DGX : 86.18 (-0.99%)
PINC : 39.68 (+0.33%)
LH : 135.70 (-1.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Sell with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade DGX with:

Business Summary

Quest Diagnostics Inc., is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers,...

See More

Key Turning Points

2nd Resistance Point 87.22
1st Resistance Point 86.70
Last Price 86.18
1st Support Level 85.67
2nd Support Level 85.16

See More

52-Week High 116.49
Fibonacci 61.8% 102.15
Fibonacci 50% 97.72
Fibonacci 38.2% 93.29
Last Price 86.18
52-Week Low 78.95

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar